Better Together… or Apart? Solutions for Struggling Joint Ventures and Minority Stakes in Portfolio Companies

May 2020

As the world battles COVID-19 and businesses experience cash constraints, underperforming joint ventures and minority stakes will come under the microscope. Following evaluation, there are usually two basic options:

1. Exit the partnership – if the contract and circumstances allow; or

2. Maintain the partnership, with an agreed plan to address problems and improve profitability.

Other reasons to exit joint ventures or sell minority stakes include:

Partner strategies diverging or markets changing so that the common interest underpinning the original business case no longer exists; or
A joint venture or minority stake – initially acquired as part of a larger acquisition – becoming value-dilutive.

 

As with divorce, deciding to re-set or exit a joint venture or sell a minority stake is not a step that a wise individual undertakes lightly. Options which align with business objectives must be weighed against what is feasible and most likely to succeed. Non-traditional leverage mechanisms, including those based on culture and environment, can be critical in negotiating an exit or agreeing on a turnaround plan for an underperforming but strategically valuable joint business.

Many corporates are familiar with these challenges; however, they can be equally relevant to private equity firms. Often, portfolio companies have entered joint ventures or bought minority stakes before the PE firm was involved. When planning their exit, PE investors need to keep the following in mind:

Uncontrolled joint ventures can negatively affect valuations. Before selling, seek to take operational control, exit or otherwise change the structure. Exiting is not easy—the other party will understand your motivation, so they will push for top dollar prices in return for a timely, straightforward deal.

 

Like neurosurgery, these are delicate processes, requiring quick, accurate diagnosis and a treatment plan unique to the specific situation. For this reason, they equally merit specialist guidance from an expert team.While some businesses are exploring the dissolution of joint ventures and sale of minority stakes at this time, others are looking to enter new ones. When planned thoughtfully and executed well, the latter can provide an antidote to current challenges and create a platform for speedier recovery and growth, as detailed in last month’s perspective Partnering to Survive Today – and Thrive Tomorrow.

Summary

Meet our Senior Team

Related Perspectives

Dividend Recapitalizations: Hit the Market Before M&A Activity Rebounds

Private debt funds have increased their dry power to $506.2 billion and acquisition-related private debt volume has reached all-time lows. As a result, private debt investors have become more aggressive… Read More

Affärsvärlden | European Companies Performing Well

Originally posted by Affärsvärlden on March 14, 2024. European companies are outperforming their U.S. counterparts. Proprietary data provided by Lincoln’s Valuations & Opinions Group revealed that European medium-sized companies are… Read More

Molecule to Market Podcast: M&A Roundtable and 2024 Predictions

Originally posted by Molecule to Market on March 8, 2024. James West, Managing Director in Lincoln’s Healthcare Group, recently joined the Molecule to Market podcast’s roundtable episode where he shared… Read More

A Paws in the March of Premium Pet: Inflationary Pressure Hits European Pet Foods

In an era where many pet owners lavish their fur babies with everything from spa treatments to gourmet meals, the premium pet food industry highlights the strong bond between humans… Read More